Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
7(54%)
Results Posted
50%(2 trials)
Terminated
1(8%)

Phase Distribution

Ph phase_1
2
15%
Ph phase_4
2
15%
Ph not_applicable
7
54%
Ph phase_2
1
8%
Ph phase_3
1
8%

Phase Distribution

2

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution13 total trials
Phase 1Safety & dosage
2(15.4%)
Phase 2Efficacy & side effects
1(7.7%)
Phase 3Large-scale testing
1(7.7%)
Phase 4Post-market surveillance
2(15.4%)
N/ANon-phased studies
7(53.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

7

trials recruiting

Total Trials

13

all time

Status Distribution
Active(8)
Completed(4)
Terminated(1)

Detailed Status

Completed4
Recruiting4
Active, not recruiting3
Terminated1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
7
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (15.4%)
Phase 21 (7.7%)
Phase 31 (7.7%)
Phase 42 (15.4%)
N/A7 (53.8%)

Trials by Status

terminated18%
not_yet_recruiting18%
active_not_recruiting323%
completed431%
recruiting431%

Recent Activity

7 active trials
Showing 5 of 13
not_yet_recruitingphase_4

Heparin to Prevent Organ Failure in Acute Pancreatitis

NCT07609771
active_not_recruitingnot_applicable

Dual-Modality Immunotherapy for HPV Clearance (DUAL-HPV)

NCT07735039
recruitingnot_applicable

Stress Reduction Through Acupuncture

NCT07132034
recruitingphase_1

Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16)

NCT07480954
recruitingphase_1

Romiplostim N01 for Platelet Recovery After Haploidentical HSCT

NCT07321626
View all 13 trials

Clinical Trials (13)

Showing 13 of 13 trials
NCT07609771Phase 4

Heparin to Prevent Organ Failure in Acute Pancreatitis

Not Yet Recruiting
NCT07735039Not Applicable

Dual-Modality Immunotherapy for HPV Clearance (DUAL-HPV)

Active Not Recruiting
NCT07132034Not Applicable

Stress Reduction Through Acupuncture

Recruiting
NCT07480954Phase 1

Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16)

Recruiting
NCT07321626Phase 1

Romiplostim N01 for Platelet Recovery After Haploidentical HSCT

Recruiting
NCT06781996Phase 3

A Study to Determine the Efficacy of a Digital Self-management Support Tool to Improve the Quality of Life During Adjuvant HOrmonal Therapy for Patients With Early Breast Cancer

Recruiting
NCT06190600Not Applicable

Supervised Physical Activity in Young Women With Early Breast Cancer During Neoadjuvant Chemotherpy

Active Not Recruiting
NCT06872372Not Applicable

Role of N-Acetylcysteine in Non-Acetaminophen-Induced Acute Liver Failure

Active Not Recruiting
NCT02522260Not Applicable

OptiTrain - Optimal Training Women With Breast Cancer

Completed
NCT02919670Not Applicable

A Study Evaluating a Proprietary Amino Acid Mixture (Enterade®) in Patients Receiving High-Dose Melphalan Conditioning Followed by Autologous Stem Cell Transplantation for Multiple Myeloma and Non-Hodgkin Lymphoma

Completed
NCT04362332Phase 4

Chloroquine, Hydroxychloroquine or Only Supportive Care in Patients AdmItted With Moderate to Severe COVID-19

Terminated
NCT02543541Not Applicable

A Pilot Study of Structured Palliative Care for Patients Enrolled on Phase I Clinical Trials

Completed
NCT01262560Phase 2

Manuka Honey in Preventing Esophagitis-Related Pain in Patients Receiving Chemotherapy and Radiation Therapy For Lung Cancer

Completed

All 13 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
13